FirstCash Holdings, Inc. (FCFS)

ShockWave Medical Stock Forecast

Stock Price Forecast

The 2 analysts that cover ShockWave Medical stock have a consensus rating of "Strong Buy" and an average price target of $133.5, which forecasts a -1.24% decrease in the stock price over the next year. The lowest target is $130 and the highest is $137.

Price Target: $133.50 (-1.24%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$130	$133.5	$137	$137
Change	-3.82%	-1.24%	+1.35%	+1.35%

* Price targets were last updated on Feb 19, 2025.

Analyst Ratings

The average analyst rating for ShockWave Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	2	2	2	2	2	1
Buy	1	1	1	1	1	1
Hold	1	1	1	1	1	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kyle Joseph Stephens & Co.	Stephens & Co.	Buy Reiterates $137	Buy	Reiterates	$137	+1.35%	Feb 19, 2025
Kyle Joseph Stephens & Co.	Stephens & Co.	Buy Initiates $137	Buy	Initiates	$137	+1.35%	Nov 13, 2024
Moshe Orenbuch TD Cowen	TD Cowen	Strong Buy Maintains $134 → $130	Strong Buy	Maintains	$134 → $130	-3.82%	Oct 28, 2024
Vincent Caintic BTIG	BTIG	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Jun 7, 2024
Anthony Chukumba Loop Capital	Loop Capital	Hold → Strong Buy Upgrades $125 → $140	Hold → Strong Buy	Upgrades	$125 → $140	+3.57%	Apr 29, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

3.54B

Increased by 4.35%

from 3.39B

Revenue Next Year

3.85B

Increased by 8.80%

from 3.54B

EPS This Year

8.12

Increased by 41.75%

from 5.73

EPS Next Year

9.77

Increased by 20.25%

from 8.12

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.63B	1.70B	2.73B	3.15B	3.39B	3.54B	3.85B	2.25B
Revenue Growth	-12.51%	4.15%	60.62%	15.50%	7.51%	4.35%	8.80%	-41.64%
EPS	2.56	3.04	5.36	4.80	5.73	8.12	9.77	13.19
EPS Growth	-32.81%	18.75%	76.32%	-10.45%	19.38%	41.75%	20.25%	35.03%
Forward PE	-	-	-	-	-	16.64	13.84	10.25
No. Analysts	-	-	-	-	-	7	7	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	3.7B	4.2B	2.3B
Avg	3.5B	3.8B	2.2B
Low	3.3B	3.5B	2.2B

Revenue Growth

Revenue Growth	2025	2026	2027
High	9.1%	18.1%	-39.9%
Avg	4.4%	8.8%	-41.6%
Low	-1.8%	-2.0%	-43.9%

EPS Forecast

EPS	2025	2026	2027
High	8.72	11.25	13.58
Avg	8.12	9.77	13.19
Low	7.55	8.73	12.67

EPS Growth

EPS Growth	2025	2026	2027
High	52.1%	38.4%	39.0%
Avg	41.8%	20.2%	35.0%
Low	31.7%	7.5%	29.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.